KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Emergent BioSolutions (EBS) Times Interest Earned (2016 - 2026)

Emergent BioSolutions has reported Times Interest Earned over the past 16 years, most recently at $0.95 for Q1 2026.

  • For Q1 2026, Times Interest Earned fell 71.88% year-over-year to $0.95; the TTM value through Mar 2026 reached $1.09, up 167.98%, while the annual FY2025 figure was $1.69, 210.26% up from the prior year.
  • Times Interest Earned for Q1 2026 was $0.95 at Emergent BioSolutions, up from -$1.9 in the prior quarter.
  • Over five years, Times Interest Earned peaked at $7.77 in Q3 2024 and troughed at -$12.29 in Q3 2023.
  • A 5-year average of -$2.57 and a median of -$1.9 in 2025 define the central range for Times Interest Earned.
  • Biggest five-year swings in Times Interest Earned: crashed 1284.87% in 2022 and later soared 163.23% in 2024.
  • Year by year, Times Interest Earned stood at -$4.32 in 2022, then soared by 53.28% to -$2.02 in 2023, then surged by 68.2% to -$0.64 in 2024, then crashed by 195.68% to -$1.9 in 2025, then surged by 150.29% to $0.95 in 2026.
  • Business Quant data shows Times Interest Earned for EBS at $0.95 in Q1 2026, -$1.9 in Q4 2025, and $5.03 in Q3 2025.